0001415889-22-000439.txt : 20220106 0001415889-22-000439.hdr.sgml : 20220106 20220106184824 ACCESSION NUMBER: 0001415889-22-000439 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20220104 FILED AS OF DATE: 20220106 DATE AS OF CHANGE: 20220106 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Xu Yuan CENTRAL INDEX KEY: 0001858214 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40925 FILM NUMBER: 22516086 MAIL ADDRESS: STREET 1: C/O AKERO THERAPEUTICS, INC. STREET 2: 601 GATEWAY BOULEVARD, SUITE 350 CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Xilio Therapeutics, Inc. CENTRAL INDEX KEY: 0001840233 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 851623397 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 BUSINESS PHONE: 617-833-1027 MAIL ADDRESS: STREET 1: 828 WINTER STREET CITY: WALTHAM STATE: MA ZIP: 02451 4 1 form4-01062022_030116.xml X0306 4 2022-01-04 0001840233 Xilio Therapeutics, Inc. XLO 0001858214 Xu Yuan C/O XILIO THERAPEUTICS, INC. 828 WINTER STREET, SUITE 300 WALTHAM MA 02451 true false false false Stock Option (right to buy) 15.92 2022-01-04 4 A 0 26400 0 A 2032-01-03 Common Stock 26400 26400 D The option award was granted on January 4, 2022 and will vest in three equal installments on January 4, 2023, January 4, 2024 and January 4, 2025. /s/ Chris Frankenfield , Attorney-in-Fact 2022-01-06